# US 2013/0281306 A1 · Sequencing methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0281306 A1
- Document ID: US20130281306A1
- Status: Published application
- Kind: A1
- Application number: 13/881,320
- Filed: 2011-10-26
- Published: 2013-10-24
- Earliest claimed: 2010-10-26
- Assignees: Illumina, Inc.
- Inventors: Roberto Rigatti; Jonathan Mark Boutell; Jason Richard Betley; Niall Anthony Gormley; Mostafa Ronaghi; Dirk Evers
- Web page: https://patentgrep.com/patent/US20130281306A1

## CPC

- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The present technology relates to molecular sciences, such as genomics. More particularly, the present technology relates to nucleic acid sequencing.

## Claims

### Claim 1

A method of generating overlapping sequencing reads, said method comprising:
providing a substrate having a surface, said surface comprising a site having a plurality of polynucleotides attached thereto; and
performing sequencing runs on said plurality of polynucleotides, said sequencing runs being initiated at different times such that said sequencing runs proceed for different durations, thereby generating a set of overlapping sequencing reads, wherein performing a sequencing run comprises:
(a) providing a first sequencing reagent to a target nucleic acid in the presence of a polymerase, said first sequencing reagent comprising one or more nucleotide monomers, wherein said one or more nucleotide monomers pair with no more than three nucleotide types in said target, thereby forming a polynucleotide complementary to at least a portion of said target; and
(b1) providing a second sequencing reagent to said target nucleic acid, said second sequencing reagent comprising at least one nucleotide monomer, said at least one nucleotide monomer of said second sequencing reagent comprising a reversibly terminating moiety, wherein said second sequencing reagent is provided subsequent to providing said first sequencing reagent, whereby sequence information for at least a portion of said target nucleic acid is obtained; or
(b2) providing a second sequencing reagent to said target nucleic acid, said second sequencing reagent comprising at least one nucleotide monomer, wherein said at least one nucleotide monomer pairs with no more than three nucleotide types in said target, wherein said second sequencing reagent is provided subsequent to providing said first sequencing reagent, and wherein a signal that indicates the incorporation of said at least one nucleotide monomer into the polynucleotide is generated, whereby sequence information for at least a portion of said target nucleic acid is obtained.

### Claim 2 (depends on 1)

The method of claim 1, further comprising the step of assembling sequencing reads from said set of overlapping sequencing reads so as to obtain a contiguous nucleotide sequence of a nucleic acid of interest.

### Claim 3 (depends on 1)

The method of claim 1, wherein providing said substrate comprises hybridizing a plurality of template nucleic acids to a plurality of capture probes attached to said site and extending said capture probes, thereby producing a plurality of polynucleotides at said site.

### Claim 4 (depends on 3)

The method of claim 3, wherein each template nucleic acid comprises an adaptor that is complementary to a capture probe attached to said site.

### Claim 5 (depends on 4)

The method of claim 4, wherein performing a sequencing run comprises extending a sequencing primer, thereby producing extended strands.

### Claim 6 (depends on 1)

The method of claim 1, wherein said plurality of polynucleotides comprises copies of the same fragment of a nucleic acid of interest.

### Claim 7 (depends on 6)

The method of claim 6, wherein said copies comprise oligonucleotide adaptors at each end.

### Claim 8 (depends on 6)

The method of claim 6, wherein each copy comprises a different sequencing primer site.

### Claim 9 (depends on 8)

The method of claim 8, wherein performing a sequencing run comprises providing sequencing primers that are complementary to said different sequencing primer sites.

### Claim 10 (depends on 6)

The method of claim 6, wherein said copies further comprise an index tag, wherein copies having the same index tag are copies of the same fragment of the nucleic acid of interest.

### Claim 11 (depends on 10)

The method of claim 10, wherein said index tag identifies sequencing reads derived from the same fragment of the nucleic acid of interest.

### Claim 12 (depends on 6)

The method of claim 6, wherein said plurality of polynucleotides further comprises copies of different fragments of the nucleic acid of interest.

### Claim 13 (depends on 12)

The method of claim 12, wherein said copies of different fragments comprise different index tags.

### Claim 14 (depends on 13)

The method of claim 13, wherein said copies of different fragments are identified by the sequence of said different index tags.

### Claim 15

A method of generating overlapping sequencing reads, said method comprising:
providing a substrate having a surface, said surface comprising a first site and a second site, said first and second sites having a plurality of polynucleotides attached thereto and said first and second sites being spatially segregated from each other; and
performing a sequencing run on said plurality of polynucleotides so as to produce an extended strand at said first and second spatially segregated sites, wherein the length of said extended strand produced at said first site is different from the length of said extended strand produced at said second site, thereby generating a set of overlapping sequencing reads, wherein performing a sequencing run comprises:
(a) providing a first sequencing reagent to a target nucleic acid in the presence of a polymerase, said first sequencing reagent comprising one or more nucleotide monomers, wherein said one or more nucleotide monomers pair with no more than three nucleotide types in said target, thereby forming a polynucleotide complementary to at least a portion of said target; and
(b1) providing a second sequencing reagent to said target nucleic acid, said second sequencing reagent comprising at least one nucleotide monomer, said at least one nucleotide monomer of said second sequencing reagent comprising a reversibly terminating moiety, wherein said second sequencing reagent is provided subsequent to providing said first sequencing reagent, whereby sequence information for at least a portion of said target nucleic acid is obtained; or
(b2) providing a second sequencing reagent to said target nucleic acid, said second sequencing reagent comprising at least one nucleotide monomer, wherein said at least one nucleotide monomer pairs with no more than three nucleotide types in said target, wherein said second sequencing reagent is provided subsequent to providing said first sequencing reagent, and wherein a signal that indicates the incorporation of said at least one nucleotide monomer into the polynucleotide is generated, whereby sequence information for at least a portion of said target nucleic acid is obtained.

### Claim at position 16

16-30. (canceled)

### Claim 31 (depends on 1)

The method of claim 1, wherein the substrate comprises a flow chamber.

### Claim 32 (depends on 1)

The method of claim 1, wherein the surface is planar.

### Claim 33 (depends on 1)

The method of claim 1, wherein the surface is patterned.

### Claim 34 (depends on 1)

The method of claim 1, wherein the surface comprises a channel in a flow chamber.

### Claim 35 (depends on 1)

The method of claim 1, wherein said site comprises a well.

### Claim 36 (depends on 1)

The method of claim 1, wherein said site comprises a bead in a well.

### Claim 37 (depends on 1)

The method of claim 1, wherein the one or more nucleotide monomers of the first sequencing reagent pair with at least two different nucleotide types in said target.

### Claim 38 (depends on 1)

The method of claim 1, wherein the one or more nucleotide monomers of the second sequencing reagent pair with at least two different nucleotide types in said target.

### Claim 39 (depends on 1)

The method of claim 1, wherein the first sequencing regent includes at least two different nucleotide monomers.

### Claim 40 (depends on 1)

The method of claim 1, wherein the one or more nucleotide monomers of the first sequencing reagent lack a reversibly terminating moiety.

### Claim 41 (depends on 1)

The method of claim 1, further comprising the step of removing the unincorporated second sequencing reagent from the substrate.

### Claim 42 (depends on 1)

The method of claim 1, further comprising the step of removing the reversibly terminating moiety from the second sequencing reagent.

### Claim 43 (depends on 42)

The method of claim 42, wherein the unincorporated first sequencing reagent is removed prior to removing the reversibly terminating moiety from the second sequencing reagent.

### Claim 44 (depends on 1)

The method of claim 1, further comprising repeating step (a) at least once prior to repeating step (b).

### Claim 45 (depends on 1)

The method of claim 1, further comprising detecting incorporation of the at least one nucleotide monomer of the second sequencing reagent into said polynucleotide.

### Claim at position 32

46-52. (canceled)
